<DOC>
	<DOCNO>NCT00516035</DOCNO>
	<brief_summary>Over past decade , avian influenza ( AI ) become major health concern . The development safe effective vaccine avian strain infect people important . The purpose study determine safety immune response new AI vaccine healthy adult H7N3 strain avian influenza .</brief_summary>
	<brief_title>Single Group Study Safety Immune Response Bird Flu Vaccine ( H7N3 ) Healthy Adults</brief_title>
	<detailed_description>The current pandemic risk associate avian influenza H7N3 infection significant increase number human infect . H7 influenza transmission usually occur human expose direct contact infect poultry surface object contaminate infected poultry feces . A pandemic occur new influenza subtype emerge infects human , cause serious illness , spread easily human . The development safe effective vaccine necessary , pandemic occur . The purpose study evaluate safety immunogenicity live , attenuate AI virus vaccine , H7N3 ( 6-2 ) AA ca Recombinant ( A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca ) . This study last approximately 90 day . Participation study include two 12-day hospital stay isolation unit Johns Hopkins Bayview Medical Center . All participant receive two dos vaccine nasal spray form , study entry sometime 4 8 week initial vaccination . Participants admitted isolation unit 2 day prior vaccination . A targeted physical exam , vital sign measurement , nasal wash occur daily follow vaccination discharge . Participants discharge three consecutive nasal wash Day 6 negative . Blood urine collection occur select timepoints throughout study . A follow-up outpatient visit occur approximately 4 week follow vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Good general health Available duration trial Willing use acceptable form contraception duration study Clinically significant neurologic , heart , lung , liver , rheumatologic , autoimmune , kidney disease Behavioral cognitive impairment psychiatric disease , opinion investigator , may affect study participation Previously enrol H7N3 influenza vaccine trial study avian influenza vaccine Seropositive H7N3 influenza A virus ( serum hemagglutination inhibition [ HI ] titer great 1:8 ) Illegal drug use dependency determine urine test Medical , work , family problem result alcohol illicit drug use within 12 month prior study entry History severe allergic reaction Allergy oseltamivir Asthma reactive airway disease within 2 year prior study entry History GuillainBarre syndrome HIV infect Hepatitis C virus infect Positive hepatitis B surface antigen ( HBsAg ) Known immunodeficiency syndrome Use corticosteroid immunosuppressive drug within 30 day prior vaccination . Participants use topical corticosteroid exclude . Live vaccine within 4 week prior study vaccination Killed vaccine within 2 week prior study vaccination Absence spleen Blood product within 6 month prior study vaccination Current smoker unwilling stop smoking duration study Have travel Southern Hemisphere , Asia , United Kingdom within 14 day prior study vaccination Have travel cruise ship within 14 day prior study vaccination Work poultry industry Other investigational vaccine drug within 30 day prior study vaccination Allergy egg egg product Purified protein derivative ( PPD ) positive ( positive tuberculosis [ TB ] test ) Have family member immunodeficiency Other condition , opinion investigator , may interfere study Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Bird Flu</keyword>
</DOC>